JTC Employer Solutions Trustee’s Gilead Sciences GILD Stock Holding History

JTC Employer Solutions Trustee’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$106K	Hold	840	–	–	0.01%	200
2026 Q1	$117K	Hold	840	–	–	0.01%	197
2025 Q4	$104K	Hold	840	–	–	0.01%	209
2025 Q3	$94K	Hold	840	–	–	0.01%	211
2025 Q2	$94K	Hold	840	–	–	0.01%	199
2025 Q1	$94K	Hold	840	–	–	0.01%	203
2024 Q4	$77K	Hold	840	–	–	0.01%	217
2024 Q3	$71K	Hold	840	–	–	﹤0.01%	228
2024 Q2	$58K	Hold	840	–	–	﹤0.01%	241
2024 Q1	$61K	Hold	840	–	–	﹤0.01%	242
2023 Q4	$68K	Hold	840	–	–	0.01%	231
2023 Q3	$63K	Hold	840	–	–	0.01%	245
2023 Q2	$64K	Hold	840	–	–	0.01%	241
2023 Q1	$69K	Hold	840	–	–	0.01%	238
2022 Q4	$72K	Hold	840	–	–	0.01%	232
2022 Q3	$51K	Buy	840 +510	+155%	+$32.2K	0.01%	211
2022 Q2	$20K	Hold	330	–	–	﹤0.01%	238
2022 Q1	$20K	Hold	330	–	–	﹤0.01%	248
2021 Q4	$24K	Hold	330	–	–	﹤0.01%	242
2021 Q3	$23K	Hold	330	–	–	﹤0.01%	248
2021 Q2	$23K	Buy	+330	New	+$22K	﹤0.01%	244

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JTC Employer Solutions Trustee's GILD Position: Q2 2026 in Review

JTC Employer Solutions Trustee held its Gilead Sciences (GILD) position steady in Q2 2026 at 840 shares worth $106K. The position accounts for 0.01% of the portfolio, ranked #200.

JTC Employer Solutions Trustee first reported a position in GILD in Q2 2021 and has held it in 21 quarters since. The position peaked at $117K in Q1 2026. 2,291 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

JTC Employer Solutions Trustee held 840 shares of Gilead Sciences worth $106K as of Q2 2026.
JTC Employer Solutions Trustee left its Gilead Sciences share count unchanged in Q2 2026.
Gilead Sciences made up 0.01% of JTC Employer Solutions Trustee's portfolio in Q2 2026, its #200 holding.
JTC Employer Solutions Trustee first reported a position in Gilead Sciences in Q2 2021 and has held it in 21 quarters since.
JTC Employer Solutions Trustee's Gilead Sciences position peaked at $117K in Q1 2026.
2,291 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on JTC Employer Solutions Trustee's 13F filing for Q2 2026, filed 31 Jul 2026.